A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1994
10/26/1994	EP0620740A1 Injectable lecithin gel
10/26/1994	EP0620739A1 Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists
10/26/1994	EP0620737A1 A lactoferrin containing therapeutic agent for rheumatism and dermatological and cosmetic compositions containing such agent.
10/26/1994	EP0620736A1 A method for the treatment of tumours and sarcomas
10/26/1994	EP0620735A1 Use of ruthenium red for inhibiting immune response
10/26/1994	EP0192667B1 Device for initiating reperfusion treatment when heart attack symptoms are present
10/26/1994	EP0174366B1 T-cell receptor-specific for antigen polypeptides and related polynucleotides
10/26/1994	CN1094093A Progenitor B cell stinulating factor
10/26/1994	CN1094092A Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides
10/26/1994	CN1094059A Insulin analogs
10/26/1994	CN1094058A Bradykinin antagonists
10/26/1994	CN1093897A Production method for surface anesthesia film
10/25/1994	US5359138 Endopeptidase inhibitors for treatment of amnesia and autoimmune diseases
10/25/1994	US5359128 Malic acid derivatives and compositions for the treatment of psoriasis
10/25/1994	US5359120 Improvements relating to the production of prodrugs
10/25/1994	US5359086 Process for preparing alkyl-L-alanyl-L-proline derivatives
10/25/1994	US5359051 Compounds useful in the synthesis of nucleic acids capable of cleaning RNA
10/25/1994	US5359047 Nucleic acids encoding DNA structure-specific recognition protein and uses therefor
10/25/1994	US5359045 DNA sequence encoding a polypeptide including nucleic acid encoding amino acids 361-404 and 951-1002
10/25/1994	US5359039 Isolated poxvirus A53R-equivalent tumor necrosis factor antagonists
10/25/1994	US5359037 Antibodies to TNF binding protein I
10/25/1994	US5359036 Growth hormone-like glycoproteins
10/25/1994	US5359035 Stable antitumor agents
10/25/1994	US5359033 Cleaved dimers of mullerian inhibiting substance-like polypeptides
10/25/1994	US5359032 Interkeukin-1 inhibitor
10/25/1994	US5359030 Coupling of a peptide and polymer; therapy, diagnosis
10/25/1994	US5358960 Method for inhibiting advanced glycosylation of proteins using aminosubstituted imidazoles
10/25/1994	US5358944 Antiinflammatory, antitumor agents, fungicides
10/25/1994	US5358935 Nonantigenic keratinous protein material
10/25/1994	US5358933 Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock
10/25/1994	US5358867 DNA cloning and expression of an L7 protein which modulates the 2'-5' oligosynthetase and H2-K*K response to type-I interferon
10/25/1994	US5358866 Using cytosine deaminase as marker
10/25/1994	US5358722 Ferritin analogs
10/25/1994	US5358710 Administering an immunosuppressant amount of a tolerogenic conjugate of an antigenic polypeptide covalently bound to a water soluble polymer
10/25/1994	US5358709 Antitumoral composition based on polypeptides having human interleukin 2 activity
10/25/1994	US5358708 Adding stabilizing amount of histidine or methionine
10/25/1994	US5358707 Oxidized variants of GM-CSF
10/25/1994	CA1332712C Intravenous pharmaceutical composition
10/23/1994	CA2121728A1 Method of treating tumor cells using antioxidants
10/23/1994	CA2121096A1 Monoclonal antibodies to bovine cytokines
10/22/1994	CA2121724A1 Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction
10/20/1994	CA2121296A1 Keyhole limpet hemocyanin composition with enhanced anti-tumor activity against bladder cancer
10/19/1994	EP0620279A1 Preparation of functional human urokinase proteins
10/19/1994	EP0620278A1 Human transaldolase and DNA encoding therefor
10/19/1994	EP0620277A1 Nucleic acid pharmaceuticals
10/19/1994	EP0620276A1 Humanised antibodies
10/19/1994	EP0620232A1 Aza cyclohexapeptide compounds
10/19/1994	EP0620230A1 Peptides and antidementia agents containing the same
10/19/1994	EP0620008A1 Use of vip, analogues and fragments thereof for the treatment of neurodegenerative diseases
10/19/1994	EP0619843A1 Icams immunoglobulin constant region soluble fusion proteins
10/19/1994	EP0619842A1 Multimeric forms of members of the steroid/thyroid superfamily of receptors
10/19/1994	EP0619841A1 T-cadherin adhesion molecule
10/19/1994	EP0619839A1 Novel polypeptides for promoting cell attachment
10/19/1994	EP0619836A1 Methods for production of purified soluble type b and type a human platelet-derived growth factor receptor fragments
10/19/1994	EP0619824A1 Trophoblast interferons and their use
10/19/1994	EP0619823A1 Peptide compounds having therapeutic activity
10/19/1994	EP0619742A1 Transfection of lung via aerosolized transgene delivery
10/19/1994	EP0619741A1 Polar lipid composition of plant origin
10/19/1994	EP0619740A1 Polyanionic polyamino acid inhibitors of mineral deposition and their synthesis
10/19/1994	EP0619739A1 Composition for irrigating intraocular tissues and maintaining mydriasis during intraocular surgery
10/19/1994	EP0619738A1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor
10/19/1994	EP0546084A4 Proteases causing abnormal degradation of amyloid -g(b)-protein precursor
10/19/1994	EP0471701B1 Novel tnf-inhibit proteins and their preparation
10/19/1994	CN1093751A Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof
10/19/1994	CN1093598A Use of Il-10 to preventor treat insulin-dependent diabetes mellitus
10/19/1994	CN1093597A Release-controlled implantable somatotropin composition
10/18/1994	US5357041 Heparin- and sulfatide-binding peptides from the type I repeats of human thrombospondin
10/18/1994	US5356896 Alkaline stabiling medium
10/18/1994	US5356895 1,4 piperizino inhibitors of non-enzymatic cross-linking of proteins
10/18/1994	US5356888 1,1-dioxo-cephem-4-carbothiolic acid derivatives
10/18/1994	US5356877 Methods for promoting growth using porcine growth hormone analogs
10/18/1994	US5356876 Methods of terminating pregnancy
10/18/1994	US5356875 Anti-thrombin polypeptides and pharmaceutical compositions thereof
10/18/1994	US5356874 Angiogenic factor isolated from live yeast cell derivatives and its use in treating wounds or burns in mammals
10/18/1994	US5356873 Method for providing nutritional requirements to patients having a chronic inflammation reaction
10/18/1994	US5356804 Cloning and expression of biologically active human α-galactosidase A
10/18/1994	US5356783 Inhibitor of tissue factor activity
10/18/1994	US5356637 Method for preparing an enzymatic hydrolysate
10/18/1994	US5356614 Process of preparing microparticulate collagen collagen-based products produced thereby and method of applying same
10/18/1994	CA1332650C Polysaccharides and antiviral drugs containing the same as active ingredient
10/18/1994	CA1332566C Agent containing aminobenzoic acid derivative as an active ingredient having an activity to reduce side effects induced by an administration of immuno-suppressant
10/17/1994	CA2094169A1 Agents for the prevention and cure of huntington disease in humans: cdna, precursor polypeptide hormone and active hormone reconstructed from the antisense strand of the huntingtondisease gene, "huntingtin"
10/13/1994	WO1994023058A1 Suppressor of hiv replication and transcription
10/13/1994	WO1994023045A1 Method of inhibiting the transcription of genes
10/13/1994	WO1994023041A2 Method for selective inactivation of viral replication
10/13/1994	WO1994023040A1 Methods and dna expression systems for over-expression of proteins in host cells
10/13/1994	WO1994023038A1 Inducible nitric oxide synthase and gene therefor
10/13/1994	WO1994023037A1 Pharmaceuticals based on papillomaviruses
10/13/1994	WO1994023035A2 RECOMBINANT TIMOTHY GRASS POLLEN ALLERGEN Phl p II
10/13/1994	WO1994023034A2 Variant insulin-like growth factor i receptor subunits and methods for use thereof
10/13/1994	WO1994023032A1 Therapeutic uses of keratinocyte growth factor
10/13/1994	WO1994023031A1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof
10/13/1994	WO1994023030A2 Methods and materials relating to the functional domains of dna binding proteins
10/13/1994	WO1994023029A1 A nucleotide sequence encoding a chromosomal protein, associated chromosomal proteins and their uses
10/13/1994	WO1994023022A1 AN α-GALACTOSIDASE ENZYME
10/13/1994	WO1994022916A1 Biologically active polypeptide fusion dimers
10/13/1994	WO1994022915A1 Inhibitor of stem cell proliferation and uses thereof
10/13/1994	WO1994022914A1 Chimeric cytokine receptors in lymphocytes
10/13/1994	WO1994022910A1 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa
10/13/1994	WO1994022909A1 NOVEL PROCESSES AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF PLATELET CLYCOPROTEIN IIb/IIIa INHIBITORS

1 ... 2874 2875 2876 2877 2878 2879 2880 2881 2882 2883 2884 2885 2886 2887 2888 2889 2890 2891 2892 2893 2894 ... 3163